Company Profile
Calviri, Inc.
Company Overview
Calviri’s mission is to End Cancer - Worldwide.
We have made the discoveries and invented the technologies that make this mission possible. We will deliver products for stage 1 cancer detection, a vaccine to treat, and ultimately a vaccine to prevent canine cancer.
Company History
In the fast-growing metroplex of Phoenix, Arizona, we formed Calviri in 2017 to end cancer. This was made feasible by our discovery of an unappreciated, yet fundamental, molecular characteristic of all tumors that distinguishes them from healthy host cells. To leverage this discovery, we invented technologies that merge biology with semiconductor chips.
These research and development efforts provided the means for diagnostics and vaccines that are unlike any others. Today, we are focused on commercializing our canine multi-cancer tests that accurately detect stage 1 disease, and our multi-cancer, early-stage therapeutic vaccines to treat it. Next, our product line will include vaccines to prevent cancers from starting. We are determined to provide diagnostics and vaccines for our pets worldwide.